Inivata Revenue and Competitors

Location

$164.4M

Total Funding

Biotech

Industry

Estimated Revenue & Valuation

  • Inivata's estimated annual revenue is currently $13.2M per year.(i)
  • Inivata's estimated revenue per employee is $155,000
  • Inivata's total funding is $164.4M.

Employee Data

  • Inivata has 85 Employees.(i)
  • Inivata grew their employee count by -47% last year.

Inivata's People

NameTitleEmail/Phone
1
Chief StaffReveal Email/Phone
2
Head PMOReveal Email/Phone
3
Head Science and Innovation and co-founderReveal Email/Phone
4
Head Assay DevelopmentReveal Email/Phone
5
Director, Corporate SystemsReveal Email/Phone
6
Director Laboratory OperationsReveal Email/Phone
7
Sr. Director, Global Supply ChainReveal Email/Phone
8
Sr. Director, PMOReveal Email/Phone
9
Director, Clinical AffairsReveal Email/Phone
10
Director Regulatory AffairsReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$11.2M72-13%N/AN/A
#2
$5099.8M32902-4%N/AN/A
#3
$1.7M110%N/AN/A
#4
$0.6M4-56%N/AN/A
#5
$0.9M11-39%N/AN/A
#6
$1.7M1110%N/AN/A
#7
$0.6M4-33%N/AN/A
#8
$4.8M31-6%N/AN/A
#9
$6.4M413%N/AN/A
#10
$4.2M27-18%N/AN/A
Add Company

What Is Inivata?

Inivata is a leader in liquid biopsy. Its InVision® platform unlocks essential genomic information from a simple blood test to transform the care of cancer patients. The Company?s technology is based on pioneering research from the Cancer Research UK Cambridge Institute, University of Cambridge and backed by multiple high calibre publications. Its lead product, InVisionFirst?-Lung, is commercially available and provides molecular insights that enable clinicians to make more informed treatment decisions for NSCLC patients. Inivata is partnering with pharmaceutical and biotechnology companies on InVisionFirst-Lung and its wider platform, which is applicable to a range of cancer types. The Company has a CLIA laboratory in Research Triangle Park, NC and R&D laboratories in Cambridge, UK. For more information, please go to www.inivata.com. Follow us on Twitter @Inivata. For more information, please go to www.inivata.com. Follow us on Twitter @Inivata.

keywords:Biotechnology

$164.4M

Total Funding

85

Number of Employees

$13.2M

Revenue (est)

-47%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Inivata News

2022-04-19 - NeoGenomics Reports Revenue of $117 Million in the First ...

Consolidated gross profit margin, including amortization of acquired Inivata developed technology intangible assets, was 32.6%. Adjusted Gross...

2022-04-06 - NeoGenomics Subsidiary Inivata And Collaborators Publish New Data On RaDaR MRD Assay At AACR 2022 Annual

NeoGenomics Subsidiary Inivata And Collaborators Publish New Data On RaDaR MRD Assay At AACR 2022 Annual Meeting ... This headline-only article is...

2022-04-06 - Inivata and Collaborators Publish New Data on RaDaR ...

Inivata and Collaborators Publish New Data on RaDaR™ MRD Assay at AACR 2022. Data demonstrates potential of RaDaR to predict clinical...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$7.5M85-10%N/A
#2
$20.9M8555%N/A
#3
$12.9M8919%N/A
#4
$16.6M95-1%N/A
#5
$14.7M950%N/A